Stablecoin evolution: Why Deloitte and NovaBay are betting on Stablecorp’s QCAD
In a latest flip of occasions, NovaBay Pharmaceuticals’ inventory jumped 18%, following the corporate’s announcement that it’s stepping away from its biotech enterprise and rebranding itself as “Stablecoin Development Corporation” (SDEV). The rebranding will take impact beginning on the third of April 2026. For perspective, the corporate has raised $134 million from main traders like…